Health Encyclopedia

 

Health Encyclopedia Home



Early Stem Cell Transplant May Benefit Some Non-Hodgkin's Lymphoma Patients

Early Stem Cell Transplant May Benefit Some Non-Hodgkin's Lymphoma Patients

THURSDAY, Oct. 31 (HealthDay News) -- Early stem cell transplants do not improve overall survival in high-risk patients with aggressive non-Hodgkin's lymphoma, but may be beneficial for a small group of patients with the very highest risk, according to a new study.

Non-Hodgkin's lymphoma is cancer of the white blood cells (lymphocytes). Larger-than-normal lymph nodes and fever are common symptoms.

Many patients with this type of cancer relapse after undergoing chemotherapy and require an autologous stem cell transplant. In that procedure, the patient's own stem cells are removed before they receive high-dose chemotherapy and/or radiation. After the chemotherapy, the patient's stem cells are returned to help replenish the body's supply of blood cells.

This study of 397 patients in the United States and Canada looked at whether giving patients a stem cell transplant before they relapsed would improve their chances of survival. The patients, who had an intermediate-high or high risk of relapse, were randomly assigned to receive an early stem cell transplant or to a "control group" that received three additional cycles of a five-drug chemotherapy regimen.

After two years, 69 percent of those in the early transplant group had no disease progression, compared with 55 percent of those in the control group. However, both groups had similar survival rates: 74 percent in the early transplant group and 71 percent in the control group, the study found.

This is probably because patients in the control group who relapsed were later offered stem cell transplants, according to Dr. Patrick Stiff, director of Loyola University Medical Center's Cardinal Bernardin Cancer Center, and colleagues.

Stem cell transplantation did not improve overall survival among the entire group of high-risk and high-intermediate risk patients, the study authors noted in a Loyola news release. However, it did appear to benefit a subgroup of high-risk patients. Among these patients, the two-year survival rate was 82 percent in the transplantation group and 64 percent in the control group, according to the report published Oct. 31 in the New England Journal of Medicine.

"Early transplantation and late transplantation appear to be roughly equivalent approaches in the treatment of the combined risk groups," the researchers concluded. However, "early transplantation appears to be beneficial for the small group of patients presenting with high-risk disease," the authors added.

It's hoped that the findings "will trigger discussions between such patients and their physicians as to the feasibility of doing early transplants," Stiff said in the news release.

More information

The U.S. National Cancer Institute has more about non-Hodgkin's lymphoma.

SOURCE: Loyola University Health System, news release, Oct. 30, 2013

 
Related Items
Wellness Library
  Learn to Be a Smart Pharmaceutical Consumer
  Medication Terms You Need to Know
  Learning to Manage Multiple Medications
  Make Friends with Your Meds
  Easy Ways to Remember to Take Your Medications
  How to Get Medications for Less
  Could Medication Be Causing Weight Gain?
  Drugs: Read Fine Print to Avoid Side Effects
  The Do's and Don’ts for Children's Meds
Quizzes
  Medication Safety Quiz
Daily News Feed
  Hodgkin Lymphoma Treatment Tied to Higher Risk of Stomach Cancer in Study
  Most Women Don't Understand Their Breast Cancer Risk: Survey
  First Generic Version of Xeloda Approved
  Kidney Damage a Risk of Some Childhood Cancer Treatments, Finds Study
  Eating, Swallowing Exercises May Aid Throat Cancer Patients
  Blood Pressure Drug Might Boost Chemo Success, Mouse Study Suggests
  Chemo After Surgery Prolongs Life in Pancreatic Cancer Patients, Study Finds
  Many People Not Told Cancer Tests Can Lead to 'Overtreatment'
  After Breast Cancer Surgery, Patient Assistance Programs Can Help
  Kids' Cancer Treatments May Cause Heart Trouble, Study Says
  Blacks Less Likely to See Cancer Specialists, Study Finds
  Money Problems Can Compromise Breast Cancer Care
  Bones Benefit From Exercise After Breast Cancer, Study Finds
  New Treatment for Aggressive Breast Cancer Shows Some Promise
  Drug May Help Slow Advanced Breast Cancer
  Chemo for Advanced Breast Cancer Might Be Enough
  2 Pre-Surgery Drug Treatments Show Promise Against Aggressive Breast Cancer
  80 Percent of Cancer Docs Have Faced Drug Shortages: Survey
  Surgery With Follow-Up Radiation Best for Tongue Cancer: Study
  Intravenous Vitamin C May Boost Chemo's Cancer-Fighting Power
  Newsman Tom Brokaw Has Many Treatment Options for His Blood Cancer
  Avastin Shows Mixed Results Against Different Cancers
  Experimental Drug May Boost Leukemia Survival, Without Chemo
  Certain Colon Cancer Patients Might Benefit From Aspirin, Study Says
  Chemo Might Give Certain Lung Cancer Patients an Edge
  Joblessness an Unwanted Side Effect of Chemo for Breast Cancer
  Gene Tests May Improve Lung Cancer Care: Study
  Memory Problems After Chemo Linked to Brain Changes
  Drug May Lower Odds of Early Menopause in Breast Cancer Patients
  Experimental Drug May Extend Lung Cancer Survival, Study Suggests
  Liver Cancer Drug Fails to Live Up to Early Promise
Adult Diseases and Conditions
  Chemotherapy for Breast Cancer Treatment
  Stroke (Brain Attack)
  Chemotherapy
  Premenstrual Syndrome (PMS)
  Cancer Treatment: Overview
  Treatment Protocols for Cancer: Overview
  Bulimia Nervosa
  Chemotherapy for Prostate Cancer
  Asthma
  Impotence/Erectile Dysfunction
Pediatric Diseases and Conditions
  Chemotherapy for Children